U.S. Food and Drug Administration Approves Flibanserin, (Female Viagra) To Aid Treatment For Sexual Desire In Women

Women who have lost their sex drive will have a little pink pill to help them come October. On Tuesday, the U.S. Food and Drug Administration approved flibanserin, which will be sold as Addyi, for the treatment of sexual dysfunction in premenopausal women.

 

Photo Credit: Today

This is the first FDA approved treatment for sexual desire in men or women.

"Today's approval provides women distressed by their low sexual desire with an approved treatment option," Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research said in a statement announcing the approval. "The FDA strives to protect and advance the health of women, and we are committed to supporting the development of safe and effective treatments for female sexual dysfunction."

Read More